For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $13.34 in the prior trading day, 10x Genomics Inc (NASDAQ: TXG) closed at $13.18, down -1.20%. In other words, the price has decreased by -$1.20 from its previous closing price. On the day, 2.02 million shares were traded. TXG stock price reached its highest trading level at $13.46 during the session, while it also had its lowest trading level at $12.96.
Ratios:
Our goal is to gain a better understanding of TXG by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.79 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 57.89. For the most recent quarter (mrq), Quick Ratio is recorded 4.12 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $35.
On July 22, 2024, Jefferies Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $24.
JP Morgan Downgraded its Overweight to Neutral on July 18, 2024, whereas the target price for the stock was revised from $40 to $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 22 ’24 when Saxonov Serge sold 6,749 shares for $22.53 per share. The transaction valued at 152,053 led to the insider holds 882,467 shares of the business.
Hindson Benjamin J. sold 4,351 shares of TXG for $98,027 on Aug 22 ’24. The insider now owns 345,704 shares after completing the transaction at $22.53 per share. On Aug 22 ’24, another insider, McAnear Justin J., who serves as the Former Chief Financial Officer of the company, sold 2,961 shares for $22.53 each. As a result, the insider received 66,710 and left with 143,242 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 1595491712 and an Enterprise Value of 1302583296. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.39 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 2.068 whereas that against EBITDA is -9.665.
Stock Price History:
Over the past 52 weeks, TXG has reached a high of $57.90, while it has fallen to a 52-week low of $13.30. The 50-Day Moving Average of the stock is -27.78%, while the 200-Day Moving Average is calculated to be -49.07%.
Shares Statistics:
The stock has traded on average 1.86M shares per day over the past 3-months and 2218040 shares per day over the last 10 days, according to various share statistics. A total of 105.04M shares are outstanding, with a floating share count of 99.73M. Insiders hold about 17.61% of the company’s shares, while institutions hold 78.84% stake in the company. Shares short for TXG as of 1730332800 were 7608141 with a Short Ratio of 4.10, compared to 1727654400 on 7437142. Therefore, it implies a Short% of Shares Outstanding of 7608141 and a Short% of Float of 8.229999000000001.
